Group 1 - The Hang Seng Index rose by 2.58% to close at 25,613.67 points on August 13 [1] - JunTai Holdings (00630.HK) closed at HKD 0.325 per share, up 14.04%, with a trading volume of 610,300 shares and a turnover of HKD 201,800, showing a volatility of 35.09% [1] - Over the past month, JunTai Holdings has had a cumulative increase of 0%, while year-to-date, it has risen by 137.5%, outperforming the Hang Seng Index by 24.48% [1] Group 2 - As of December 31, 2024, JunTai Holdings reported total revenue of HKD 34.9969 million, a year-on-year increase of 10.07%, and a net profit attributable to shareholders of -HKD 1.1418 million, a year-on-year increase of 55.21% [1] - The gross profit margin for JunTai Holdings is 36.89%, and the debt-to-asset ratio is 62.26% [1] - Currently, there are no institutional investment ratings for JunTai Holdings [2] Group 3 - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -0.03 times, with a median of 1.37 times [2] - JunTai Holdings has a P/E ratio of -223.64 times, ranking 56th in the industry [2] - Other companies in the industry include Jingjiu Healthcare (00648.HK) at 0.38 times, Giant Medical Holdings (02393.HK) at 0.4 times, Yihui Group (08161.HK) at 2.35 times, Global Medical (02666.HK) at 5.3 times, and Ruici Medical (01526.HK) at 5.35 times [2] Group 4 - JunTai Holdings is a company registered in Bermuda, with its shares listed on the Hong Kong Stock Exchange since 1996 [2] - The company primarily engages in the manufacturing and sales of medical equipment products, plastic mold products, and data media products [2] - The company expanded its medical equipment and plastic mold manufacturing and sales business through the acquisition of the Titron Group in October 2011 [2] Group 5 - Important date: The company will disclose its interim report for the fiscal year 2025 on August 29, 2025 [3]
隽泰控股（00630.HK）8月13日收盘上涨14.04%，成交20.18万港元